Solid-State Battery Goes Into Iron Humanoid, First for Bipedal Robots

Ecovacs' Deebot T90S Pro Omni pairs a rotating mop roller with a self-emptying, self-washing dock at a mid-range price, and an early Notebookcheck review rates its value for money as outstanding. The model succeeds a well-regarded predecessor and shows how a feature once reserved for flagship machines is migrating down the product stack. For manufacturers, it is another sign that the premium tier is being squeezed from below, and that hardware differentiation is getting harder to defend.

Opentrons Labworks closed a $40 million Series E led by healthcare investor Avego, money earmarked for robotics hardware, software, and data infrastructure. The round arrives as pharma and biotech labs push to replace bespoke, hand-built workflows with standardized automation. The company is betting that the lasting advantage in lab robotics sits in the data layer rather than the pipetting arm, a thesis that puts it in direct competition with entrenched incumbents like Hamilton and Tecan.

VisioSurgical Solutions (VSS), a Lausanne-based startup founded by the team behind the first retinal surgery robot, has launched and begun developing a compact system aimed at putting robotic assistance within reach of every retina surgeon. Retinal procedures demand precision at the edge of human physiological limits, yet robotic adoption has stayed marginal. VSS is betting that smaller, simpler hardware, not more capability, is what the market has been missing.

Agility Robotics and Churchill Capital Corp XI said on October 30, 2026 that the humanoid maker's gross capital raise tied to their business combination should reach roughly $465 million before expenses. The figure arrives after Churchill XI's redemption deadline expired, meaning the number reflects what shareholders actually left in the trust rather than what was hoped for. For a company selling Digit into warehouses, it is a hard measure of public-market appetite for humanoid commercialization.

The FCC has moved to cut Chinese-made drones, routers, and connected home devices off from the US market by freezing equipment authorizations rather than passing a formal import ban. The approach hits DJI and Autel hardest today, but the same legal machinery now threatens robot vacuums and other networked machines built on Chinese hardware. For robotics firms, the real exposure sits in the supply chain: modules, radios, and chipsets that never appear on a product label.

The Robot Report's 2026 Robotics Handbook compiles engineering analysis of the design decisions shaping dexterous manipulation, humanoid platforms, and construction automation. Rather than celebrating capability milestones, the handbook concentrates on the tradeoffs underneath them: actuator selection, hand complexity, sensing, and where AI belongs in the control stack. For engineers and investors evaluating humanoid programs, it offers a framework for judging which architectural bets are likely to survive contact with production environments and real customer economics.

A humanoid robot with a chainsaw mounted on one arm appeared on Japanese television news cutting back tree branches that had grown toward railway lines. The footage, reported by Tom's Hardware UK, shows autonomous AI systems being applied to a dangerous, labor-intensive maintenance task that Japan's aging rail workforce increasingly struggles to staff. For robotics engineers and investors, the demonstration points to infrastructure upkeep as a practical proving ground for humanoid platforms, where the commercial case rests on safety and labor scarcity rather than novelty.

Dr. Vipul Patel, founder and medical director of the Global Robotics Institute at AdventHealth Celebration, performed a robotic telesurgery on a patient at a hospital 35 miles away, a first in Florida according to ABC News. The procedure moves remote surgery from conference demo toward clinical routine. For robotics suppliers, the real story is not the distance but the latency, redundancy, and regulatory architecture that made a 35-mile operation defensible.

A DARPA demonstration at Fort Knox showed autonomous ground vehicles detecting, tracking, and engaging simulated threats while a human operator retained control of the engagement decision. The effort builds on the agency's RACER off-road autonomy program, which was designed for speed and navigation rather than weapons integration. The exercise points to a growing defense market for modular autonomy software, and raises hard questions about operator workload and command-link resilience.

Unitree Robotics' shares have climbed more than 60% in under two weeks on China's STAR Market, even as the humanoid maker formally cautioned investors about the commercial prospects of its own product category. The rally shows how far retail and institutional appetite for embodied AI has run ahead of the sector's revenue base. For robotics executives and investors, the gap between the company's sober disclosures and the market's enthusiasm is the clearest signal yet of valuation risk in the humanoid trade.

Realbotix has opened a direct-to-consumer website for its Echo line of humanoid robots, taking orders for companionship, education, and wellness use with limited quantities slated for 2027 delivery. The Las Vegas-based, TSX-V-listed company is betting that consumers, not enterprises, will fund the next phase of humanoid production. For an industry fixated on factory floors and warehouse pilots, Realbotix is testing whether emotional engagement can sell hardware at retail.

Brian Lenihan, a Dublin marathon runner, underwent robotic surgery at St Vincent's University Hospital to construct a neobladder, an internal replacement bladder built from the patient's own intestinal tissue. He is now training to race again. The case shows how robot-assisted platforms are moving into long, technically punishing reconstructive procedures once performed almost exclusively through open surgery. For manufacturers and hospital buyers, functional outcomes such as returning to endurance sport are becoming the metric that justifies robotic capital spending.